microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis
Authors
Keywords
miR-181a, Glioblastoma, microRNA replacement therapy, Carmustine, AKT signaling
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 888, Issue -, Pages 173483
Publisher
Elsevier BV
Online
2020-08-16
DOI
10.1016/j.ejphar.2020.173483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma
- (2019) Sotirios Katsigiannis et al. Radiation Oncology
- Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
- (2019) Luca Lignitto et al. CELL
- MicroRNA‐193a and taxol combination: A new strategy for treatment of colorectal cancer
- (2019) Maryam Hejazi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care
- (2019) Shufeng Yi et al. Artificial Cells Nanomedicine and Biotechnology
- Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
- (2019) Olivia G. Taylor et al. Frontiers in Oncology
- microRNA-181 serves as a dual-role regulator in the development of human cancers
- (2019) Tayebeh Rezaei et al. FREE RADICAL BIOLOGY AND MEDICINE
- Defining the Akt1 interactome and its role in regulating the cell cycle
- (2018) Shweta Duggal et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs in cancer drug resistance: Basic evidence and clinical applications
- (2018) Mehri Ghasabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities
- (2018) Zahra Asadzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA in Glioblastoma: An Overview
- (2017) Barbara Banelli et al. International Journal of Genomics
- BACH1, the master regulator gene: A novel candidate target for cancer therapy
- (2016) Sadaf Davudian et al. GENE
- The correlation of microRNA-181a and target genes with poor prognosis of glioblastoma patients
- (2016) SHI-XIONG HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
- (2016) Angeliki Tiptiri-Kourpeti et al. PHARMACOLOGY & THERAPEUTICS
- Epithelial-mesenchymal transition in glioblastoma progression
- (2016) YASUO IWADATE Oncology Letters
- MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
- (2016) Amanda Shea et al. Cancer Medicine
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma
- (2014) XIAOLING SHE et al. ONCOLOGY REPORTS
- miRNA dysregulation in cancer: towards a mechanistic understanding
- (2014) Jayanth Kumar Palanichamy et al. Frontiers in Genetics
- MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targetingKRAS,PIK3CDandBCL2
- (2013) Wen-Ting Liao et al. JOURNAL OF PATHOLOGY
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
- (2012) H. Li et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity
- (2012) B. Zhou et al. DIABETOLOGIA
- MicroRNA-181a – a tale of discrepancies
- (2012) Aliaa M. Seoudi et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Drug Resistance in Glioblastoma: A Mini Review
- (2012) Catherine P. Haar et al. NEUROCHEMICAL RESEARCH
- SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines
- (2012) Yan Qu et al. NEUROSCIENCE LETTERS
- Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo
- (2012) R B Luwor et al. ONCOGENE
- Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer
- (2011) W. Dong et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells
- (2011) Aruna Venkata Badiga et al. PLoS One
- BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
- (2010) Thomas Reithmeier et al. BMC CANCER
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Bcl2 family proteins in carcinogenesis and the treatment of cancer
- (2009) Anna Frenzel et al. APOPTOSIS
- hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
- (2008) Lei Shi et al. BRAIN RESEARCH
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- miR-34a repression of SIRT1 regulates apoptosis
- (2008) M. Yamakuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started